Guardant Health, Inc. — Director's Dealing 2021

Jan 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Guardant Health, Inc. (GH)
CIK: 0001576280
Period of Report: 2021-01-01

Reporting Person: Eltoukhy Helmy (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-01	COMMON STOCK	M	565192	—	Acquired	3408645	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-01	Performance-Based Restricted Stock Units	$	M	565192	Disposed	2027-05-26	COMMON STOCK (565192.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
COMMON STOCK	664020	Indirect

Footnotes

F1: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2: One-third of the granted performance-based restricted stock units vested and converted into shares of common stock based on the Issuer's achievement of the stock price milestone, as certified by the Issuer's compensation committee on January 2, 2021.